Yahoo
Stockholm - Delayed Quote SEK

ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)

0.9280 -0.0720 (-7.20%)
At close: November 6 at 5:21:20 PM GMT+1
View in AlphaSpace Currency in SEK All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-47,773 -40,904 -33,928 -100,887 -99,614
Cash Flow from Investing Activities
-307 0 21,275 -2,015 105,325
Cash Flow from Financing Activities
35,671 10,782 34,871 47,836 61,460
Cash and Cash Equivalents, End of Period
34,378 47,555 81,541 57,597 110,974
Cash Flow, Supplemental
Free Cash Flow to Firm
-34,077.4619 -33,370.2105 -58,450.0766 -93,745.9297 -113,591.8826
Capital Expenditure, Calculated
307 0 870 2,015 383
Issuance of Capital Stock
44,446 12,096 42,340 60,719 75,960
Repurchase of Capital Stock
-8,490 -839 -7,351 -10,484 -12,185
12/31/2022 - 7/29/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: